等待开盘 11-05 09:30:00 美东时间
0.000
0.00%
Transaction Includes Concurrent $160 million Private Investment in Public Equity (PIPE) Financing and Expected Gross Proceeds of Approximately $246 million TriGemX Bio, a biotechnology company focused on developing elismetrep, a potential first-in-class treatment for migraine, and TCGX Acquisition C...
10-19 19:07
An announcement from TCGX Acquisition Corp. Class A ( ($TCGX) ) is now availabl...
08-07 05:45
TCGX Acquisition (TCGX) priced its IPO of 7.5M Class A ordinary shares at $10.00 per share, raising $75M. The Class A ordinary shares are expected to begin trading on the Nasdaq Capital Market under t...
08-05 15:24
CENTENNIAL, CO / ACCESSWIRE / October 2, 2023 / NioCorp Developments Ltd. ("Nio...
2023-10-02 23:10
CENTENNIAL, CO / ACCESSWIRE / September 26, 2023 / NioCorp Developments Ltd. ("...
2023-09-26 19:00
NEW YORK, March 17, 2023 (GLOBE NEWSWIRE) -- GX Acquisition Corp. II (NasdaqCM:...
2023-03-17 23:46
北京时间2023年03月17日21时50分,Gx Acquisition Corp Ii(GXII.us)股票出现异动,股价快速上涨5.09%。截至发稿,该股报...
2023-03-17 22:40